CAS: 28862-79-5; Z-D-Leu-Oh

该化合物是氨基酸 Leucine的衍生物,其特点是存在苯氧基碳基(Z)保护群体,该化合物通常用于peptide合成和研究,因为它有能力在化学反应中保护氨基的 Leucine.Z-D-lecine是白到白的结晶粉,溶于有机溶剂,如甲醇和二甲基硫氧化物,但水中溶液较少.其分子结构包括一个分支的液态侧链,有助于其防水的特性.Z组的存在提高了合成期间氨基酸的稳定性,使其成为生产peptides和药品的宝贵中间体.此外,Z-D-leucine可用于与蛋白折叠和功能有关的研究,以及各种生物活性化合物的开发.它与许多氨基酸衍生物的分泌相结合,对于处理Z-D的适当实验室安全性安排非常重要.

结构式图片

相似化合物

3588-60-1 103478-62-2 103478-63-3

上下游产品

CAS号328-38-1 D-亮氨酸 | CAS号501-53-1 氯甲酸苄酯 | CAS号2018-66-8 N-苄氧羰基-L-亮氨酸 | CAS号64-17-5 乙醇 | CAS号174657-99-9 (R)-4-nitrobenz... | CAS号70853-26-8 L-N-benzyloxyca... | CAS号328-39-2 (±)-氨基-4-甲基戊酸 | CAS号328-38-1 D-亮氨酸 | CAS号65581-25-1 CBZ-D-亮氨酸N-羟基琥珀酰亚胺脂

合成工艺路线路线简述

    L-亮氨醇置于jones' Reagent,三乙胺体系中,用 二氯甲烷,丙酮 用作溶剂,化学反应 7.0H,反应生成N-苄氧羰基-D-亮胺酸
    参考文献:Kashima,Choji; Harada,Kazuo; Fujioka,Yoko,Journal Of The Chemical Society. Perkin Transactions I,1988,P. 535-540
    标题:Kashima,Choji; Harada,Kazuo; Fujioka,Yoko,Journal Of The Chemical Society. Perkin Transactions I,1988,P. 535-540

    海关参考信息

    专利信息


    专利号:US-7435791-B2
    优先权日:2001-07-19
    标题:Process for rapid solution synthesis of peptides
    发明人:EGGEN IVO FRANCI; TEN KORTENAAR PAULUS BERNARDUS; HAASNOOT CORNELIS ALBERT GRUSON
    权利人:ORGANON NV
    摘要:The present invention relates to a process for rapid solution synthesis of a peptide, the process comprising repetitive cycles of steps (a)-(d):n (a) a coupling step, using an excess of an activated carboxylic component to acylate an amino component, (b) a quenching step in which a scavenger is used to remove residual activated carboxylic functions, wherein the scavenger may also be used for deprotection of the growing peptide, (c) one or more aqueous extractions and optionally, (d) a separate deprotection step, followed by one or more aqueous extractions, characterised in that the process comprises at least one step (b), referred to as step (b′), in which an amine or a thiol comprising a free anion or a latent anion is used as a scavenger of residual activated carboxylic functions. nn During the process of this invention the growing peptide need not be isolated until the final peptide sequence has been obtained. n This highly efficient process is useful for the production of oligo- and polypeptides of high purity.

    专利号:US-11634741-B2
    优先权日:2013-11-20
    标 题:Synthesis of L-nucleic acids by means of an enzyme
    发明人:PECH ANDREAS; JAROSCH FLORIAN; JAHNZ MICHAEL; KLUSSMANN SVEN; DAVID RALF
    权利人:APTARION BIOTECH AG
    摘要:The present invention is related to a method for adding one or more L-nucleotides to the 3′end of a first L-nucleic acid, wherein the method comprises the step of reacting the one or more L-nucleotides with the first L-nucleic acid in the presence of a protein comprising a mutant enzymatic activity exhibiting moiety, wherein the enzymatic activity is capable of adding one or more L-nucleotides to the 3′ end of the first L-nucleic acid, wherein the mutant enzymatic activity exhibiting moiety comprises an amino acid sequence, wherein the amino acids of the amino acid sequence are D-amino acids, wherein the mutant enzymatic activity exhibiting moiety is a variant of an enzymatic activity exhibiting moiety, wherein the enzymatic activity exhibiting moiety consists of an amino acid sequence according to SEQ ID NO: 15 and wherein the amino acids of the amino acid sequence according to SEQ ID NO: 15 are D-amino acids, wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety differs from the amino acid sequence of the enzymatic activity exhibiting moiety consisting of an amino acid sequence according to SEQ ID NO: 15 at least at one amino acid position, preferably at three amino acid positions, and/or wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety is a truncated form of an amino acid sequence according to SEQ ID NO: 15, and wherein the amino acid sequence of the mutant enzymatic activity exhibiting moiety is different from an amino acid sequence according to any of SEQ ID NOs 15 to 22 and 51.

    专利号:US-6380156-B1
    优先权日:1996-10-24
    标 题:Total synthesis of the amino hip analogue of didemnin A
    发明人:RINEHART KENNETH L; KATAUSKAS ALEXANDRA J
    权利人:UNIV ILLINOIS
    摘要:Disclosed is a synthetic method for the preparation of analogs of Didemnin A (1), particularly the Amino-Hip analog of Didemnin A, also known as 'AipDidemnin A' (8). These compounds have the following structures:

    专利号:US-4301065-A
    优先权日:1977-05-25
    标 题 :Novel polypeptides having thymic activity or an antagonistic activity and processes for their synthesis
    发明人:BACH JEAN-FRANCOIS; DARDENNE MIREILLE; PLEAU JEAN-MARIE; HAMBURGER JEAN; BRICAS EVANGHELOS; MARTINEZ JEAN; BLANOT DIDIER; AUGER GENEVIEVE
    权利人:ANVAR
    摘要:The invention is concerned with novel polypeptides and processes for the synthesis thereof. It is concerned with compounds having the sequence X-Gln-Gly-Gly-Y in which Y represents -Ser-Asn and X represents Ser-, Lys-Ser-, Ala-Lys-Ser-, Glx-Ala-Lys-Ser-; Glx representing Pyro-Glu or Gln; and when X represents Glx-Ala-Lys-Ser-, Y may in addition represent -Ser; as well as their derivatives comprising one or two modified amino acids, with the exception of the unmodified compound PyroGlu-Ala-Lys-Ser-Gln-Gly-Ser-Asn. These polypeptides are useful as medicines.

    专利号:US-2018208910-A1
    优先权日:2012-05-16
    标 题 :Enzymatic Synthesis of L-Nucleic Acids

    专利号:EP-3071702-B1
    优先权日:2013-11-20
    标题 :Synthesis of l-nucleic acids by means of an enzyme
    苏州奥格尼克生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.organic-biotechnology.com
    企业联系电话:18061997750👤
    📞苏州奥格尼克生物科技有限公司 ⚠️参考联系方式
    联系人:过经理
    电话:18061997750
    手机:18061997750
    传真:QQ:1255618855
    邮箱:info@organic-biotechnology.com
    通信地址: 江苏苏州张家港市杨舍镇东方新天地9幢B308
    邮编: 215600
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏苏州张家港市杨舍镇东方新天地9幢B308
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海庭园生化科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.gdbiochem.com.cn
    电话: 021-50800786👤
    📞上海庭园生化科技有限公司 ⚠️参考联系方式

    销售电话:021-50800786
    邮箱:sales@gdbiochem.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    摘要:Wolkenberg, S. E.; Garbaccio, R. M., Science of Synthesis, (2007) 20, 429.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知